4D Biomaterials, a medtech company which has developed a new biomaterial used for 3D printing medical implants, has completed a £1.6m funding round led by DSW Ventures.

Patchwork Health, the healthcare staffing platform founded by doctors, has raised £3.5m to accelerate their mission to solve the NHS burnout crisis. The funding, from Praetura Ventures and BMJ New Ventures, comes as an NHS workforce 'emergency' is declared and waiting lists reach record highs.

Leo Cancer Care is an innovative start-up company that is set to change the face of Radiation Therapy forever. They recently completed their Series B fundraising activities, through parent company Asto CT Inc. alongside the team at Pureland Global Venture. The fundraise has seen investments from investors located all across the globe, some of the largest investors in the fundraise alongside Pureland were investment companies Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.

Calculus Capital and Foresight Group have successfully sold Mologic Limited, a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

Foresight Group LLP, an award-winning listed infrastructure and regional private equity investment manager, has sold Mologic Limited, a World leading innovator in lateral flow and rapid diagnostic technologies and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

TravelPerk cofounder launches mental health startup Oliva backed by Moonfire Ventures.

Viracoat, a subsidiary of Viracorp set up to develop and produce PPE that begins killing COVID-19 and other viruses on contact, has raised £2million ($4million Australian dollars) to fund final stages of accreditation and further UK based research. The funding comes from J.J. Richards & Sons Pty Ltd, an Australian, family owned and operated business that provides waste management service solutions throughout Australia and New Zealand and already has a successful scientific and medical distribution subsidiary.

Sweden’s largest providers of digital healthcare, Doktor.se, has secured €29.5 million from Tencent Holdings.

A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m.

Nottingham-based NuVision Biotherapies  has secured funding from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s EIS funds, Newable Ventures and private investors.

A business that is on course to transform the food allergy diagnostics market has secured £2.9m investment in a funding round led by Praetura Ventures with follow-on equity investment from the Development Bank of Wales.  Reacta Biotech (Reacta), which is based in Deeside, North Wales, produces clinical diagnostics kits for food allergy testing. The business improves the efficiency, accuracy and safety of food allergy testing by producing pharmaceutical grade Oral Food Challenges (OFCs), the gold standard test for diagnosing food allergies.

Livingbridge has announced its investment in AJM Healthcare, the leading provider of NHS wheelchair services in England.  AJM provides services for over 100,000 wheelchair users across 13 locations.  It delivers a high quality, clinically led service focused on meeting the diverse needs of users.  AJM draws on the deep experience of its more than 270 staff to ensure leading outcomes and best-in-class service for both commissioners and service users.

IW Capital has made an investment in e-pharmacy company SimplyMeds, marking the first external investment in the highly scalable online platform.

SimplyMeds is an end-to-end digital pharmacy platform that provides a convenient method of ordering same day prescriptions and lifestyle products while empowering patients to have medical autonomy. While most online pharmacies are designed to service only one sector, SimplyMeds caters to both the private and NHS prescriptions market in what is believed to be a market first, having developed the distribution channels and a highly sophisticated platform to effectively serve both sectors.